首页> 外文期刊>American Journal of Bioscience and Bioengineering >Evaluation of Pro-Inflammatory Cytokines Expression in Mouse Splenocyte Cells After Incubation with the Biofield Energy Healing Based Herbomineral Formulation: Influence of the Trivedi Effect
【24h】

Evaluation of Pro-Inflammatory Cytokines Expression in Mouse Splenocyte Cells After Incubation with the Biofield Energy Healing Based Herbomineral Formulation: Influence of the Trivedi Effect

机译:基于生物场能量治疗的中草药配方培养后小鼠脾细胞中促炎细胞因子表达的评估:Trivedi效应的影响

获取原文
           

摘要

The use of herbomineral formulations in the healthcare sector has increased due to their high safety and better therapeutic action. A new proprietary herbomineral formulation was formulated with a combination of the herbal root extract ashwagandha and minerals viz. zinc, magnesium, and selenium. The aim of the study was to evaluate the immunomodulatory potential of Biofield Energy Healing (The Trivedi Effect) on the test formulation in splenocytes. The test formulation was divided into two parts; one was the control without the Biofield Energy Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment remotely by seven renowned Biofield Energy Healers. The MTT assay showed that the test formulation exhibited safe concentrations up to 1.053 μg/mL with cell viability ranging from 88.19% to 110.30% in the Biofield Energy Treated sample. The Biofield Energy Healing significantly enhanced the cell viability as compared with the untreated test formulation. The expression of TNF-α was significantly inhibited by 7.23% at 1.053 μg/mL in the Biofield Energy Treated test formulation compared with the vehicle control. The level of TNF-α was significantly decreased by 3.90%, 11.74%, 3.12%, and 9.17% at 0.001053, 0.01053, 0.1053 and 1.053 μg/mL, respectively in the Biofield Energy Treated test formulation compared with the untreated test formulation. Additionally, the expression of IL-1β was significantly reduced by 28.98%, 51.23%, 53.06%, 48.98%, 55.71%, and 59.10% at 0.00001053, 0.0001053, 0.001053, 0.01053, 0.1053, and 1.053 μg/mL, respectively in the Biofield Energy Treated test formulation compared with the vehicle control. Further, the Biofield Treated test formulation showed significant reduction of IL-1β by 35.07% (p≤0.05), 47.46% (p≤0.05), and 57.51% (p≤0.01) at 0.001053, 0.1053, and 1.053 μg/mL, respectively compared with the untreated test formulation. Similarly, the MIP-1α expression was inhibited by the Biofield Energy Treated formulation and showed immunosuppressive activity at 0.00001053, 0.0001053, 0.001053, and 0.01053 μg/mL by 19.38%, 24.97%, 31.23%, and 25.41%, respectively compared with the vehicle control group. The Biofield Treated test formulation significantly (p<0.001) reduced the MIP-1α expression by 19.33%, 22.57%, and 30.50% at 0.0001053, 0.001053, and 0.01053 μg/mL, respectively compared with the untreated test formulation. Overall, The Trivedi Effect - Biofield Energy Healing (TEBEH) significantly down-regulated the pro-inflammatory cytokines and potentiated the immunosuppressive effect of the Biofield Energy Treated test formulation, which can be better utilized for organ transplants, autoimmune diseases, inflammatory disorders, anti-aging, stress management, overall health and quality of life, etc.
机译:由于它们的高安全性和更好的治疗作用,其在医疗保健领域的使用已越来越多。结合草药根提取物ashwagandha和矿物质vis配制了一种新的专有植物矿物质配方。锌,镁和硒。这项研究的目的是评估脾脏细胞中测试制剂的生物场能量治疗(Trivedi效应)的免疫调节潜力。测试配方分为两部分:一个是没有进行生物场能量治疗的对照,而另一部分则定义为经过生物场能量治疗的样品,该样品由七位著名的生物场能量治疗师远程接受了生物场能量治疗。 MTT分析表明,在经过Biofield Energy处理的样品中,测试制剂的安全浓度高达1.053μg/ mL,细胞活力范围为88.19%至110.30%。与未处理的测试制剂相比,Biofield能量修复显着增强了细胞活力。与载体对照相比,在Biofield Energy处理的测试制剂中,TNF-α的表达在1.053μg/ mL时显着抑制了7.23%。与未处理的测试制剂相比,在Biofield Energy处理的测试制剂中,TNF-α的水平在0.001053、0.01053、0.1053和1.053μg/ mL时分别显着降低了3.90%,11.74%,3.12%和9.17%。此外,在0.00001053、0.0001053、0.001053、0.01053、0.1053和1.053μg/ mL处,IL-1β的表达分别显着降低了28.98%,51.23%,53.06%,48.98%,55.71%和59.10%。与车辆对照相比,经过Biofield Energy处理的测试配方。此外,经Biofield处理的测试制剂在0.001053、0.1053和1.053μg/ mL的浓度下,IL-1β显着降低了35.07%(p≤0.05),47.46%(p≤0.05)和57.51%(p≤0.01),分别与未处理的测试制剂进行比较。同样,MIP-1α的表达受到Biofield Energy处理的制剂的抑制,与载体相比,在0.00001053、0.0001053、0.001053和0.01053μg/ mL处的免疫抑制活性分别为19.38%,24.97%,31.23%和25.41%。控制组。与未处理的测试制剂相比,经Biofield处理的测试制剂在0.0001053、0.001053和0.01053μg/ mL的条件下显着(p <0.001)使MIP-1α表达分别降低了19.33%,22.57%和30.50%。总体而言,Trivedi效应-生物场能量治疗(TEBEH)显着下调了促炎细胞因子,并增强了生物场能量治疗测试制剂的免疫抑制效果,该制剂可更好地用于器官移植,自身免疫性疾病,炎症性疾病,抗衰老,压力管理,整体健康和生活质量等

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号